NKCFO LLC’s Apyx Medical APYX Stock Holding History

NKCFO LLC’s Portfolio APYX Stock Details APYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-15,200	Closed	-$96K	–	103
2019 Q1	$96K	Hold	15,200	–	–	0.07%	79
2018 Q4	$98K	Buy	+15,200	New	+$92.1K	0.08%	64

Other funds holding APYX

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CAM

Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

HKAM

Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return

TFCM

Taylor Frigon Capital Management Scottsdale, Arizona $214M AUM 47.29% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NKCFO LLC's APYX Position: Q2 2019 in Review

NKCFO LLC sold out of Apyx Medical (APYX) in Q2 2019, closing a stake of 15,200 shares — an estimated $96K sold.

NKCFO LLC first reported a position in APYX in Q4 2018 and held it in 2 quarters. The position peaked at $98K in Q4 2018. 66 funds tracked by Wall St. Rank hold APYX as of Q2 2019.

NKCFO LLC reported no remaining Apyx Medical position as of Q2 2019 after selling out during the quarter.
NKCFO LLC sold 15,200 Apyx Medical shares in Q2 2019, an estimated $96K.
NKCFO LLC first reported a position in Apyx Medical in Q4 2018 and held it in 2 quarters.
NKCFO LLC's Apyx Medical position peaked at $98K in Q4 2018.
66 funds tracked by Wall St. Rank held Apyx Medical as of Q2 2019.

Based on NKCFO LLC's 13F filing for Q2 2019, filed 31 Jul 2019.